EVOXAC Rx

Select the drug indication to add to your list

EVOXAC

Dry mouth
Only 4 drugs may be compared at once

Generic Name and Formulations:

Cevimeline HCl 30mg; caps.

Company:

Daiichi Sankyo

Select therapeutic use:

Indications for EVOXAC:

Dry mouth associated with Sjogren's syndrome.

Adult:

30mg three times daily.

Children:

Not recommended.

Contraindications:

Uncontrolled asthma. When miosis is undesirable (eg, acute iritis, narrow-angle glaucoma).

Warnings/Precautions:

History of cardiovascular disease. Controlled asthma. Chronic bronchitis. COPD. History of nephrolithiasis or cholelithiasis. CYP2D6 deficiency. Pregnancy (Cat.C). Nursing mothers: not recommended.

Interactions:

Potentiated by CYP2D6 and CYP3A3/4 inhibitors. Possible conduction disturbances with β-adrenergic antagonists. Additive effects with parasympathomimetics. May interfere with antimuscarinics.

Pharmacological Class:

Cholinergic.

Adverse Reactions:

Excessive sweating (dehydration may develop; drink extra water), rhinitis, excessive salivation, UTI, cough, arthralgia, fatigue, insomnia, hot flushes, GI upset, visual disturbances (eg, blurring, decreased visual acuity), others.

How Supplied:

Caps—100

EVOXAC 30mg capsules (Qty:90)

appx. price $665.00